Gaining a better understanding of the reason underlying the accumulation of phosphorylated tau in the nuclei of HSV-1-infected neuronal cells and the details of its interaction with viral chromatin, could pave the way to develop innovative therapeutic strategies for HSV-1-associated neurodegenerative diseases. This evidence concerns the gene MAPT and neurodegenerative disease.